Literature DB >> 28780659

Preconception Counseling for Women With Cardiac Disease.

Mark A Clapp1,2, Sarah N Bernstein3,4.   

Abstract

OPINION STATEMENT: All providers who care for reproductive-aged women with cardiac disease should assess these patients' desires and plans for pregnancy at every encounter. For those considering pregnancy, preconception counseling, often performed by a maternal-fetal medicine specialist, can help patients understand the potential implications of pregnancy on their health and estimate the risks of an adverse cardiac event prior to conceiving. There are cardiac conditions, such as pulmonary hypertension and aortic stenosis, in which pregnancy may be contraindicated given the high morbidity and mortality; there are tools available to help quantify a patient's risk. Furthermore, some cardiac lesions may be inherited, which may warrant parental testing or a discussion of strategies to reduce the risk of an affected child, such as the use of assisted reproductive technologies. Preconception counseling is also important to identify other maternal risk factors, such as obesity, hypertension, and tobacco use, which are associated with adverse pregnancy outcomes and develop a strategy to mitigate their potential risks, ideally before pregnancy. For women on medications for their heart disease or other comorbidities, a thorough review of these medications can potentially avoid an exposure to a teratogen during conception and pregnancy. Once pregnant, a patient's obstetrical provider and cardiologist should work together to outline a plan to monitor a patient's cardiac status as the normal physiologic changes of pregnancy, such as increased blood volume and cardiac output, may challenge a patient's functional status and increase the risk for an adverse outcome. Labor and delivery planning are essential to ensure patients with cardiac disease deliver at the appropriate hospital, equipped with the staff and resources to care for women with complex conditions. In summary, preconception counseling aims to stratify a patient's risk in pregnancy, inform patients of possible complications, and discuss strategies to best ensure a healthy mother and baby during pregnancy, labor, and delivery.

Entities:  

Keywords:  Cardiac disease; Obstetrics; Preconception counseling; Pregnancy

Year:  2017        PMID: 28780659     DOI: 10.1007/s11936-017-0565-z

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  21 in total

1.  Prospective multicenter study of pregnancy outcomes in women with heart disease.

Authors:  S C Siu; M Sermer; J M Colman; A N Alvarez; L A Mercier; B C Morton; C M Kells; M L Bergin; M C Kiess; F Marcotte; D A Taylor; E P Gordon; J C Spears; J W Tam; K S Amankwah; J F Smallhorn; D Farine; S Sorensen
Journal:  Circulation       Date:  2001-07-31       Impact factor: 29.690

2.  The risk for congenital heart defects in offspring of individuals with congenital heart defects.

Authors:  O Romano-Zelekha; R Hirsh; L Blieden; M Green; T Shohat
Journal:  Clin Genet       Date:  2001-05       Impact factor: 4.438

Review 3.  Clinical practice. Chronic hypertension in pregnancy.

Authors:  Ellen W Seely; Jeffrey Ecker
Journal:  N Engl J Med       Date:  2011-08-04       Impact factor: 91.245

4.  Drugs in pregnancy: Implications for a cardiologist.

Authors:  Karel Rakusan
Journal:  Exp Clin Cardiol       Date:  2010

5.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

Authors:  Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2005-06-12       Impact factor: 91.245

6.  Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study.

Authors:  Mary C M Macintosh; Kate M Fleming; Jaron A Bailey; Pat Doyle; Jo Modder; Dominique Acolet; Shona Golightly; Alison Miller
Journal:  BMJ       Date:  2006-06-16

7.  Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease.

Authors:  Ali Balci; Krystyna M Sollie-Szarynska; Antoinette G L van der Bijl; Titia P E Ruys; Barbara J M Mulder; Jolien W Roos-Hesselink; Arie P J van Dijk; Elly M C J Wajon; Hubert W Vliegen; Willem Drenthen; Hans L Hillege; Jan G Aarnoudse; Dirk J van Veldhuisen; Petronella G Pieper
Journal:  Heart       Date:  2014-07-17       Impact factor: 5.994

8.  Adverse Pregnancy Outcomes Using The International Association of the Diabetes and Pregnancy Study Groups Criteria: Glycemic Thresholds and Associated Risks.

Authors:  David A Sacks; Mary Helen Black; Xia Li; Martin N Montoro; Jean M Lawrence
Journal:  Obstet Gynecol       Date:  2015-07       Impact factor: 7.661

9.  Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada.

Authors:  Raluca Ionescu-Ittu; Ariane J Marelli; Andrew S Mackie; Louise Pilote
Journal:  BMJ       Date:  2009-05-12

10.  Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes.

Authors:  Shiliang Liu; K S Joseph; Wei Luo; Juan Andrés León; Sarka Lisonkova; Michiel Van den Hof; Jane Evans; Ken Lim; Julian Little; Reg Sauve; Michael S Kramer
Journal:  Circulation       Date:  2016-08-30       Impact factor: 29.690

View more
  2 in total

1.  Reducing Disparities in Severe Maternal Morbidity and Mortality.

Authors:  Elizabeth A Howell
Journal:  Clin Obstet Gynecol       Date:  2018-06       Impact factor: 2.190

Review 2.  Pulmonary Hypertension in Pregnancy: Challenges and Solutions.

Authors:  Hesham Afify; Alexander Kong; Jopher Bernal; Islam Y Elgendy
Journal:  Integr Blood Press Control       Date:  2022-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.